Patents
Metabolex receives European patent for metaglidasen in type 2 diabetes, obesity, others
Published in Obesity and Diabetes Week, December 4th, 2006
The patent covers the use of metaglidasen and a number of chemically similar compounds for treating type 2 diabetes, insulin resistance, impaired glucose tolerance and obesity.
The European patent further strengthens Metabolex's intellectual property position surrounding metaglidasen, which Metabolex is now evaluating in a pivotal phase 2/3 trial of patients with type 2 diabetes. The company has 14 issued patents covering...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity Therapy
Phase I/IIa clinical trial of CYT009-GhrQb as obesity vaccine shows no effect on weight loss - Obesity and Diabetes
Investigators at Max Planck Institute for Psychiatry have published new data on obesity and diabetes - Obesity and Diabetes
New obesity and diabetes research has been reported by scientists at Institute of Medicine - Obesity and Diabetes
New obesity and diabetes study findings have been reported by scientists at University of Adelaide, Department of Endocrinology - Obesity and Diabetes
New obesity and diabetes study findings have been reported from Institutes of Health - Obesity and Diabetes
New obesity and diabetes study findings recently were published by researchers at National University, Department of Biological Sciences - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
